Racial Disparities in Diabetes Technology Adoption and Their Association with HbA1c and Diabetic Ketoacidosis

References

• Agarwal S, Kanapka LG, Raymond JK, et al. Racial-ethnic inequity in young adults with type 1 diabetes. J Clin Endocrinol Metab. 2020;105(8):e2960–9. PubMed PMID: 32382736; PMCID: PMC7457963. doi:10.1210/clinem/dgaa236
   PubMed Web of Science ®Google Scholar
• Willi SM, Miller KM, DiMeglio LA, et al. Racial-ethnic disparities in management and outcomes among children with type 1 diabetes. Pediatrics. 2015;135(3):424–434. PubMed PMID: 25687140; PMCID: PMC4533245. doi:10.1542/peds.2014-1774
   PubMed Web of Science ®Google Scholar
• Agarwal S, Schechter C, Gonzalez J, Long JA. Racial-ethnic disparities in diabetes technology use among young adults with type 1 diabetes. Diabetes Technol Ther. 2021;23(4):306–313. PubMed PMID: 33155826; PMCID: PMC7994432. doi:10.1089/dia.2020.0338
   PubMed Web of Science ®Google Scholar
• Valenzuela JM, La Greca AM, Hsin O, Taylor C, Delamater AM. Prescribed regimen intensity in diverse youth with type 1 diabetes: role of family and provider perceptions. Pediatr Diabetes. 2011;12(8):696–703. PubMed PMID: 21457425. doi:10.1111/j.1399-5448.2011.00766.x
   PubMed Web of Science ®Google Scholar
• Paris CA, Imperatore G, Klingensmith G, et al. Predictors of insulin regimens and impact on outcomes in youth with type 1 diabetes: the SEARCH for Diabetes in Youth study. J Pediatr. 2009;155(2):183–9.e1. PubMed PMID: 19394043. doi:10.1016/j.jpeds.2009.01.063
   PubMed Web of Science ®Google Scholar
• Lin MH, Connor CG, Ruedy KJ, et al. Race, socioeconomic status, and treatment center are associated with insulin pump therapy in youth in the first year following diagnosis of type 1 diabetes. Diabetes Technol Ther. 2013;15(11):929–934. PubMed PMID: 23869706; PMCID: PMC3817890. doi:10.1089/dia.2013.0132
   PubMed Web of Science ®Google Scholar
• Shah VN, Akturk HK, Joseph H, Schneider N, Snell-Bergeon JK. A randomized controlled trial of transition from insulin pump to multiple daily injections using insulin degludec. Diabetes Obes Metab. 2021;23(8):1936–1941. PubMed PMID: 34180122. doi:10.1111/dom.14423
   PubMed Web of Science ®Google Scholar
• Dubé MC, Lavoie C, Weisnagel SJ. Glucose or intermittent high-intensity exercise in glargine/glulisine users with T1DM. Med Sci Sports Exerc. 2013;45(1):3–7. PubMed PMID: 22895370. doi:10.1249/MSS.0b013e31826c6ad3
   PubMed Web of Science ®Google Scholar
• Fonseca VA, Grunberger G, Anhalt H, et al. Continuous glucose monitoring: a consensus conference of the American Association of Clinical Endocrinologists and American College of Endocrinology. Endocr Pract. 2016;22(8):1008–1021. PubMed PMID: 27214060. doi:10.4158/ep161392.Cs
   PubMed Web of Science ®Google Scholar
• Maahs DM, Chase HP, Westfall E, et al. The effects of lowering nighttime and breakfast glucose levels with sensor-augmented pump therapy on hemoglobin A1c levels in type 1 diabetes. Diabetes Technol Ther. 2014;16(5):284–291. PubMed PMID: 24450776. doi:10.1089/dia.2013.0227
   PubMed Web of Science ®Google Scholar
• Yardley JE, Iscoe KE, Sigal RJ, Kenny GP, Perkins BA, Riddell MC. Insulin pump therapy is associated with less post-exercise hyperglycemia than multiple daily injections: an observational study of physically active type 1 diabetes patients. Diabetes Technol Ther. 2013;15(1):84–88. PubMed PMID: 23216304. doi:10.1089/dia.2012.0168
   PubMed Web of Science ®Google Scholar
• Berget C, Akturk HK, Messer LH, et al. Real-world performance of hybrid closed loop in youth, young adults, adults and older adults with type 1 diabetes: identifying a clinical target for hybrid closed-loop use. Diabetes Obes Metab. 2021;23(9):2048–2057. PubMed PMID: 34010499. doi:10.1111/dom.14441
   PubMed Web of Science ®Google Scholar
• Akturk HK, Giordano D, Champakanath A, Brackett S, Garg S, Snell-Bergeon J. Long-term real-life glycaemic outcomes with a hybrid closed-loop system compared with sensor-augmented pump therapy in patients with type 1 diabetes. Diabetes Obes Metab. 2020;22(4):583–589. PubMed PMID: 31789447. doi:10.1111/dom.13933
   PubMed Web of Science ®Google Scholar
• Garg SK, Weinzimer SA, Tamborlane WV, et al. Glucose outcomes with the in-home use of a hybrid closed-loop insulin delivery system in adolescents and adults with type 1 diabetes. Diabetes Technol Ther. 2017;19(3):155–163. PubMed PMID: 28134564; PMCID: PMC5359676. doi:10.1089/dia.2016.0421
   PubMed Web of Science ®Google Scholar
• Tauschmann M, Thabit H, Bally L, et al. Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial. Lancet. 2018;392(10155):1321–1329. PubMed PMID: 30292578; PMCID: PMC6182127. doi:10.1016/s0140-6736(18)31947-0
   PubMed Web of Science ®Google Scholar
• Bergenstal RM, Garg S, Weinzimer SA, et al. Safety of a hybrid closed-loop insulin delivery system in patients with type 1 diabetes. JAMA. 2016;316(13):1407–1408. PubMed PMID: 27629148. doi:10.1001/jama.2016.11708
   PubMed Web of Science ®Google Scholar
• Brown SA, Kovatchev BP, Raghinaru D, et al. Six-month randomized, multicenter trial of closed-loop control in type 1 diabetes. N Engl J Med. 2019;381(18):1707–1717. PubMed PMID: 31618560; PMCID: PMC7076915. doi:10.1056/NEJMoa1907863
   PubMed Web of Science ®Google Scholar
• Snyder LL, Stafford JM, Dabelea D, et al. Socio-economic, demographic, and clinical correlates of poor glycaemic control within insulin regimens among children with Type 1 diabetes: the SEARCH for diabetes in youth Study. Diabet Med. 2019;36(8):1028–1036. PubMed PMID: 31050009; PMCID: PMC6635011. doi:10.1111/dme.13983
   PubMed Web of Science ®Google Scholar
• Akturk HK, Agarwal S, Hoffecker L, Shah VN. Inequity in racial-ethnic representation in randomized controlled trials of diabetes technologies in type 1 diabetes: critical need for new standards. Diabetes Care. 2021;44(6):e121–e3. PubMed PMID: 34016613; PMCID: PMC8247501. doi:10.2337/dc20-3063
   PubMed Web of Science ®Google Scholar
• Bergenstal RM, Tamborlane WV, Ahmann A, et al. Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med. 2010;363(4):311–320. PubMed PMID: 20587585. doi:10.1056/NEJMoa1002853
   PubMed Web of Science ®Google Scholar
• Sawyer A, Sobczak M, Forlenza GP, Alonso GT. Glycemic control in relation to technology use in a single-center cohort of children with type 1 diabetes. Diabetes Technol Ther. 2022;24(6):409–415. PubMed PMID: 35099306; PMCID: PMC9208858. doi:10.1089/dia.2021.0471
   PubMed Web of Science ®Google Scholar
• Forlenza GP, Vigers T, Berget C, et al. Predicting success with a first-generation hybrid closed-loop artificial pancreas system among children, adolescents, and young adults with type 1 diabetes: a model development and validation study. Diabetes Technol Ther. 2022;24(3):157–166. PubMed PMID: 34780306; PMCID: PMC8971998. doi:10.1089/dia.2021.0326
   PubMed Web of Science ®Google Scholar
• Cobry EC, Hamburger E, Jaser SS. Impact of the hybrid closed-loop system on sleep and quality of life in youth with type 1 diabetes and their parents. Diabetes Technol Ther. 2020;22(11):794–800. PubMed PMID: 32212971; PMCID: PMC7698988. doi:10.1089/dia.2020.0057
   PubMed Web of Science ®Google Scholar
• Fazeli Farsani S, Brodovicz K, Soleymanlou N, Marquard J, Wissinger E, Maiese BA. Incidence and prevalence of diabetic ketoacidosis (DKA) among adults with type 1 diabetes mellitus (T1D): a systematic literature review. BMJ Open. 2017;7(7):e016587. PubMed PMID: 28765134; PMCID: PMC5642652. doi:10.1136/bmjopen-2017-016587
   PubMed Web of Science ®Google Scholar
• Lyerla R, Johnson-Rabbett B, Shakally A, Magar R, Alameddine H, Fish L. Recurrent DKA results in high societal costs - a retrospective study identifying social predictors of recurrence for potential future intervention. Clin Diabetes Endocrinol. 2021;7(1):13. PubMed PMID: 34332631; PMCID: PMC8325863. doi:10.1186/s40842-021-00127-6
   PubMedGoogle Scholar
• Nathan DM, Genuth S, Lachin J, et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977–986. PubMed PMID: 8366922. doi:10.1056/nejm199309303291401
   PubMed Web of Science ®Google Scholar
• Lachin JM, Orchard TJ, Nathan DM. Update on cardiovascular outcomes at 30 years of the diabetes control and complications trial/epidemiology of diabetes interventions and complications study. Diabetes Care. 2014;37(1):39–43. PubMed PMID: 24356596; PMCID: PMC3868002. doi:10.2337/dc13-2116
   PubMed Web of Science ®Google Scholar
• Cleary PA, Orchard TJ, Genuth S, et al. The effect of intensive glycemic treatment on coronary artery calcification in type 1 diabetic participants of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study. Diabetes. 2006;55(12):3556–3565. PubMed PMID: 17130504; PMCID: PMC2701297. doi:10.2337/db06-0653
   PubMed Web of Science ®Google Scholar
• Kaur H, Schneider N, Pyle L, Campbell K, Akturk HK, Shah VN. Efficacy of hybrid closed-loop system in adults with type 1 diabetes and gastroparesis. Diabetes Technol Ther. 2019;21(12):736–739. PubMed PMID: 31347928. doi:10.1089/dia.2019.0254
   PubMed Web of Science ®Google Scholar
• Choudhary P, Kolassa R, Keuthage W, et al. Advanced hybrid closed loop therapy versus conventional treatment in adults with type 1 diabetes (ADAPT): a randomised controlled study. Lancet Diabetes Endocrinol. 2022;10(10):720–731. PubMed PMID: 36058207. doi:10.1016/s2213-8587(22)00212-1
   PubMed Web of Science ®Google Scholar
• Ware J, Boughton CK, Allen JM, et al. Cambridge hybrid closed-loop algorithm in children and adolescents with type 1 diabetes: a multicentre 6-month randomised controlled trial. Lancet Digit Health. 2022;4(4):e245–e255. PubMed PMID: 35272971. doi:10.1016/s2589-7500(22)00020-6
   PubMedGoogle Scholar
• Messer LH, Forlenza GP, Sherr JL, et al. Optimizing hybrid closed-loop therapy in adolescents and emerging adults using the miniMed 670G system. Diabetes Care. 2018;41(4):789–796. PubMed PMID: 29444895; PMCID: PMC6463622. doi:10.2337/dc17-1682
   PubMed Web of Science ®Google Scholar
• Everett E, Mathioudakis N. Association of area deprivation and diabetic ketoacidosis readmissions: comparative risk analysis of adults vs children with type 1 diabetes. J Clin Endocrinol Metab. 2019;104(8):3473–3480. PubMed PMID: 31220288; PMCID: PMC6599429. doi:10.1210/jc.2018-02232
   PubMed Web of Science ®Google Scholar
• Bergmann KR, Nickel A, Hall M, et al. Association of neighborhood resources and race and ethnicity with readmissions for diabetic ketoacidosis at US Children’s hospitals. JAMA Netw Open. 2022;5(5):e2210456. doi:10.1001/jamanetworkopen.2022.10456
   PubMed Web of Science ®Google Scholar
• Berry JG, Hall DE, Kuo DZ, et al. Hospital utilization and characteristics of patients experiencing recurrent readmissions within children’s hospitals. JAMA. 2011;305(7):682–690. PubMed PMID: 21325184; PMCID: PMC3118568. doi:10.1001/jama.2011.122
   PubMed Web of Science ®Google Scholar
• Alonso GT, Ebekozien O, Gallagher MP, et al. Diabetic ketoacidosis drives COVID-19 related hospitalizations in children with type 1 diabetes. J Diabetes. 2021;13(8):681–687. PubMed PMID: 33855813; PMCID: PMC8251108. doi:10.1111/1753-0407.13184
   PubMed Web of Science ®Google Scholar
• Ebekozien O, Agarwal S, Noor N, et al. Inequities in diabetic ketoacidosis among patients with type 1 diabetes and COVID-19: data from 52 US clinical centers. J Clin Endocrinol Metab. 2021;106(4):e1755–e1762. PubMed PMID: 33410917; PMCID: PMC7928931. doi:10.1210/clinem/dgaa920
   PubMedGoogle Scholar
• Langendam M, Luijf YM, Hooft L, Devries JH, Mudde AH, Scholten RJ. Continuous glucose monitoring systems for type 1 diabetes mellitus. Cochrane Database Syst Rev. 2012;1(1):Cd008101. doi:10.1002/14651858.CD008101.pub2
   PubMedGoogle Scholar